Last reviewed · How we verify

NCT06358248: SPHERE

Standardized Physician-modified Fenestrated Endograft Registry

Recruiting now Last updated 16 April 2024
What this trial tests

trial testing Physician-modification of Valiant Captivia Endograft (Medtronic, Minneapolis, MN-USA). in Aortic Aneurysm, Thoracoabdominal in 50 participants. Currently enrolling.

Timeline
1 October 2023
Primary endpoint
1 October 2028
1 October 2033

Quick facts

Lead sponsorUniversity Hospital Padova
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment50
Start date1 October 2023
Primary completion1 October 2028
Estimated completion1 October 2033
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital Padova

Who can join

Adults 18 to 100, any sex, with Aortic Aneurysm, Thoracoabdominal or Aortic Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Multicenter retrospective study including all consecutive patients treated by PMEG using a standard modification technique of Valiant Captivia (Medtronic, Minneapolis, MN-USA).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Aortic Aneurysm, Thoracoabdominal

Currently open trials in the same condition.

Other University Hospital Padova trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06358248.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing